Defects in the endolysosomal pathway have been observed in Alzheimer’s disease (AD) models, resulting in aberrant release of Amyloid Precursor Protein (APP) species in exosomes, allowing for elimination of lysosomal contents that cannot be efficiently degraded (Miranda et al., 2018). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.